Beruflich Dokumente
Kultur Dokumente
In-Hospital Management of
Diabetes
Chapter 16
Janine Malcolm MD FRCPC, Ilana Halperin MD FRCPC, David
Miller MD FRCPC, Sarah Moore RN(EC) BScN MN, Kara
Nerenberg MD FRCPC, Vincent Woo MD FRCPC, Catherine Yu
MD FRCPC
Disclaimer
For permission to use this slide deck for commercial or any use
other than personal, please contact guidelines@diabetes.ca
2018 Diabetes Canada CPG – Chapter 16. In-hospital Management of Diabetes
2018
Key Changes
• New recommendations for:
• screening hospitalized patients with newly diagnosed
hyperglycemia, diabetes risk factors, or pre-existing
diabetes with A1C
• frequency and timing of bedside CBG monitoring
• use of IV insulin infusion for perioperative management
of patients undergoing CABG to prevent surgical site
infections
• post-operative protocols using basal/bolus therapy in
patients with diabetes requiring insulin therapy
• New glycemic targets for various categories of in-
hospital people with diabetes
In-hospital Management
Checklist
CHECK A1C if it has not been done in the last 3 months
CONTINUE pre-hospital diabetes regimen if appropriate,
otherwise …
USE insulin as the treatment of choice
DO NOT use sliding scale insulin alone
DO use BASAL + BOLUS + CORRECTION insulin
regimen
AVOID hypoglycemia
In-hospital Hyperglycemia is
Common
• Approximately 1/3 of
in-patients have been
found to have
Hyperglycemia
hyperglycemia
Acute Illness
Hyperglycemia
Less stringent targets may be appropriate in terminally ill patients or in people with severe
comorbidities
CABG, coronary artery bypass grafting PERSONAL USE ONLY
2018 Diabetes Canada CPG – Chapter 16. In-hospital Management of Diabetes
6U 6U 6U Basal
insulin
ROUTINE Bolus insulin Routine Basal
PERSONAL USE ONLY
2018 Diabetes Canada CPG – Chapter 16. In-hospital Management of Diabetes
12.2
11.1
*
11.1 *
* SSI * SSI
¶
¶
10.0
¶ 10.0
¶ ŧ
ŧ †
8.9 8.9 †
7.8
7.8
6.7
*p < 0.01; ¶p < 0.05. BBI *p < 0.001, ŧp = 0.02, †p = 0.01 BBI
5.6 6.7
Admit 1 2 3 4 5 6 7 8 9 10 Randomi 1 2 3 4 5 6 7 8 9
-zation
Duration of treatment (days) Duration of treatment (days)
Avoid Hypoglycemia
• Protocols for hypoglycemia avoidance, recognition and
management should be implemented with nursing-
initiated treatment
• Patients at risk of hypoglycemia should have ready
access to an appropriate source of glucose at all times
• Insulin protocols and order sets may be used to
improve adherence to optimal insulin use and
glycemic control
Organization of Care
• Institution wide programs with the following
elements can result in improvements in in-hospital
glycemic control:
• Inter-professional team based care
• Health-care professional development focused
on in-hospital diabetes management
• Algorithms, order sets and decision support
• Comprehensive quality assurance initiatives
2018
Recommendation 1
1. An A1C should be measured if not done in the 3 months prior
to admission on:
• All hospitalized people with a history of diabetes to identify
individuals that would benefit from glycemic optimization
[Grade D, Consensus]
• All hospitalized people with newly diagnosed
hyperglycemia or those with diabetes risk factors to
identify individuals at risk for ongoing dysglycemia [Grade C,
Level 3]
• Repeat screening should be performed 6 to 8 weeks post
hospital discharge for individuals with an A1C 6.0%-6.4%
[Grade D, Consensus]
• In-hospital CBG monitoring should be initiated for
individuals with an A1C ≥6.5% [Grade D, Consensus]
2018
Recommendation 2
2. The frequency and timing of bedside CBG
monitoring should be individualized for all in-
hospital people with diabetes. Monitoring should
typically be performed:
• Before meals and at bedtime in people who are
eating [Grade D, Consensus]
• Every 4 to 6 hours in people who are NPO or
receiving continuous enteral feeding [Grade D,
Consensus]
• Every 1 to 2 hours for people on continuous
intravenous insulin or those who are critically ill
[Grade D, Consensus]
Recommendation 3
3. Provided that their medical conditions, dietary intake
and glycemic control are stable, people with diabetes
should be maintained on their pre-hospitalization
non-insulin antihyperglycemic agents or insulin
regimens [Grade D, Consensus]
Recommendation 4
4. For hospitalized people with diabetes treated with
insulin, a proactive approach that includes basal,
bolus and correction (supplemental) insulin,
along with pattern management, should be used to
reduce adverse events and improve glycemic control,
instead of only correcting high BG with short- or
rapid-acting insulin [Grade A, Level 1A]
Recommendation 5
5. For the majority of non-critically ill hospitalized
people with diabetes, preprandial BG targets should
be 5.0 to 8.0 mmol/L in conjunction with random BG
values <10.0 mmol/L, as long as these targets can
be safely achieved [Grade D, Consensus]
Recommendation 6
6. For most medical/surgical critically ill hospitalized
people with diabetes with hyperglycemia, a
continuous intravenous insulin infusion should be
used to maintain BG <10.0 mmol/L [Grade B, Level 2]
and >6.0 mmol/L [Grade D, Consensus]
2018
Recommendation 7
7. For people with diabetes undergoing CABG, a
continuous IV insulin infusion protocol targeting
intraoperative glycemic levels between 5.5 and 11.1
mmol/L should be used, rather than subcutaneous
insulin, to prevent postoperative infections [Grade A,
Level 1A]
2018
Recommendation 8
8. In hospitalized people with diabetes requiring insulin
therapy, protocols using basal insulin with/without
bolus insulin should be used for postoperative
glycemic management [Grade B, Level 2]
Recommendation 9
9. In hospitalized people with diabetes, hypoglycemia
should be minimized. Protocols for hypoglycemia
avoidance, recognition and management should be
implemented with nurse-initiated treatment,
including glucagon for severe hypoglycemia when
intravenous access is not readily available [Grade D,
Consensus]. Hospitalized people with diabetes at risk
of hypoglycemia should have ready access to an
appropriate source of glucose (oral or IV) at all times,
particularly when NPO or during diagnostic
procedures [Grade D, Consensus]
2018
Recommendation 10
10. Programs consisting of the following elements should
be implemented for optimal inpatient diabetes care:
• Interprofessional team-based approach [Grade B, Level 2]
• Health-care professional development regarding in-
hospital diabetes management [Grade D, Level 4]
• Algorithms, order sets and decision support [Grade C, Level
3]
• Comprehensive quality assurance initiatives including
institution-wide BG monitoring systems, inpatient education,
and transition/continuity of care and discharge planning
[Grade D, Consensus]
Key Messages
• Hyperglycemia is common in hospitalized people,
even among those without a previous history of
diabetes, and is associated with increased in-hospital
complications, longer length of stay, and mortality
Key Messages
• Insulin is the most appropriate pharmacologic agent
for effectively controlling glycemia in hospital.
Key Messages
• Glycemic targets for the majority of non-critically ill
hospitalized people with diabetes are:
• preprandial 5.0 to 8.0 mmol/L, in conjunction with
random BG <10.0 mmol/L, as long as these targets
can be safely achieved.
Key Messages
• Hypoglycemia is a major barrier to achieving targeted
glycemic control in the hospital setting.
• Health-care institutions should develop protocols for
the assessment and treatment of hypoglycemia
1-800-BANTING (226-8464)